Viewing Study NCT03419559


Ignite Creation Date: 2025-12-24 @ 2:40 PM
Ignite Modification Date: 2026-01-02 @ 11:06 AM
Study NCT ID: NCT03419559
Status: WITHDRAWN
Last Update Posted: 2019-04-16
First Post: 2018-01-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung Cancer
Sponsor: Iovance Biotherapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module